Double Total Stockholder Equity vs Accounts Payable Analysis

002901 Stock   32.54  0.06  0.18%   
Double Medical financial indicator trend analysis is much more than just examining Double Medical Technology latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Double Medical Technology is a good investment. Please check the relationship between Double Medical Total Stockholder Equity and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Double Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Stockholder Equity vs Accounts Payable

Total Stockholder Equity vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Double Medical Technology Total Stockholder Equity account and Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Double Medical's Total Stockholder Equity and Accounts Payable is 0.95. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Double Medical Technology, assuming nothing else is changed. The correlation between historical values of Double Medical's Total Stockholder Equity and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Double Medical Technology are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Stockholder Equity i.e., Double Medical's Total Stockholder Equity and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.95
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Accounts Payable

An accounting item on the balance sheet that represents Double Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Double Medical Technology are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Double Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Double Medical Technology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Double Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
As of December 10, 2024, Tax Provision is expected to decline to about 12.7 M. In addition to that, Selling General Administrative is expected to decline to about 440.3 M
 2021 2022 2023 2024 (projected)
Net Interest Income13.7M17.6M22.4M16.3M
Tax Provision111.0M37.9M13.4M12.7M

Double Medical fundamental ratios Correlations

0.870.880.8-0.780.640.740.910.880.360.770.870.910.710.86-0.650.860.660.560.86-0.060.740.870.80.390.84
0.870.970.76-0.780.740.890.950.970.320.790.980.920.890.9-0.90.870.790.560.910.270.750.980.840.420.84
0.880.970.75-0.840.740.820.930.930.480.790.950.930.780.86-0.870.950.770.520.860.240.740.950.880.440.93
0.80.760.75-0.450.750.750.770.80.180.830.790.860.730.78-0.610.760.680.670.770.050.80.790.570.620.64
-0.78-0.78-0.84-0.45-0.68-0.64-0.8-0.8-0.31-0.73-0.82-0.78-0.56-0.770.69-0.82-0.67-0.54-0.77-0.03-0.7-0.8-0.93-0.5-0.89
0.640.740.740.75-0.680.770.810.86-0.010.940.840.830.670.89-0.630.740.920.830.860.050.930.840.830.790.75
0.740.890.820.75-0.640.770.810.90.040.880.890.760.930.85-0.870.650.690.810.860.30.870.920.680.60.67
0.910.950.930.77-0.80.810.810.970.30.820.960.960.780.97-0.730.890.890.590.960.090.780.960.920.410.88
0.880.970.930.8-0.80.860.90.970.170.890.990.950.880.98-0.820.850.870.710.980.160.861.00.890.550.84
0.360.320.480.18-0.31-0.010.040.30.170.010.20.29-0.040.08-0.260.580.11-0.30.040.19-0.060.20.28-0.280.57
0.770.790.790.83-0.730.940.880.820.890.010.870.830.760.89-0.690.740.790.920.880.071.00.880.790.830.76
0.870.980.950.79-0.820.840.890.960.990.20.870.950.890.95-0.870.870.850.660.960.20.831.00.890.560.84
0.910.920.930.86-0.780.830.760.960.950.290.830.950.770.94-0.730.930.860.580.930.030.790.940.890.520.87
0.710.890.780.73-0.560.670.930.780.88-0.040.760.890.770.81-0.870.60.630.660.850.410.740.90.60.520.54
0.860.90.860.78-0.770.890.850.970.980.080.890.950.940.81-0.690.810.920.731.00.040.870.960.90.550.81
-0.65-0.9-0.87-0.610.69-0.63-0.87-0.73-0.82-0.26-0.69-0.87-0.73-0.87-0.69-0.72-0.59-0.51-0.71-0.44-0.66-0.87-0.67-0.49-0.69
0.860.870.950.76-0.820.740.650.890.850.580.740.870.930.60.81-0.720.780.430.780.080.690.860.880.430.96
0.660.790.770.68-0.670.920.690.890.870.110.790.850.860.630.92-0.590.780.610.880.010.770.840.880.50.78
0.560.560.520.67-0.540.830.810.590.71-0.30.920.660.580.660.73-0.510.430.610.740.020.950.690.570.860.5
0.860.910.860.77-0.770.860.860.960.980.040.880.960.930.851.0-0.710.780.880.740.060.870.960.880.550.78
-0.060.270.240.05-0.030.050.30.090.160.190.070.20.030.410.04-0.440.080.010.020.060.060.21-0.020.050.04
0.740.750.740.8-0.70.930.870.780.86-0.061.00.830.790.740.87-0.660.690.770.950.870.060.850.750.850.72
0.870.980.950.79-0.80.840.920.961.00.20.881.00.940.90.96-0.870.860.840.690.960.210.850.880.550.84
0.80.840.880.57-0.930.830.680.920.890.280.790.890.890.60.9-0.670.880.880.570.88-0.020.750.880.480.93
0.390.420.440.62-0.50.790.60.410.55-0.280.830.560.520.520.55-0.490.430.50.860.550.050.850.550.480.43
0.840.840.930.64-0.890.750.670.880.840.570.760.840.870.540.81-0.690.960.780.50.780.040.720.840.930.43
Click cells to compare fundamentals

Double Medical Account Relationship Matchups

Double Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Other Liab30.7M59.6M61.8M56.1M64.5M48.1M
Net Tangible Assets1.4B1.7B2.0B2.3B2.6B1.5B
Retained Earnings891.0M1.3B1.6B1.2B1.3B920.1M
Other Assets6.6M100.9M9.4M66.4M76.4M80.2M
Other Stockholder Equity(134.0K)112.6K(2.5M)(1.7M)(1.5M)(1.4M)
Deferred Long Term Liab3.1M2.8M2.4M57.3M65.9M69.2M
Common Stock401.9M402.3M402.2M405.1M465.9M429.3M
Property Plant Equipment276.9M443.0M513.7M698.7M803.5M402.2M
Total Assets2.2B2.6B3.4B3.9B4.6B2.8B
Other Current Liab153.0M180.8M289.1M16.7M21.3M20.3M
Total Current Liabilities425.8M441.8M721.8M716.6M1.2B1.2B
Total Stockholder Equity1.7B2.1B2.5B3.0B3.1B2.2B
Accounts Payable211.1M179.8M296.3M345.4M281.6M193.5M
Cash764.6M562.9M410.2M992.7M1.2B737.2M
Non Current Assets Total591.1M663.4M984.8M1.2B1.5B799.6M
Non Currrent Assets Other93.7M676.2K899.5K4.7M1.9M1.8M
Net Receivables242.7M290.9M467.8M324.7M242.4M245.0M
Non Current Liabilities Total59.6M61.8M69.7M114.5M325.4M341.7M
Inventory457.1M542.0M670.2M987.4M1.2B615.0M
Other Current Assets24.6M21.7M36.0M13.0M26.1M28.8M
Total Liab485.3M503.7M791.5M831.1M1.5B1.6B
Total Current Assets1.6B2.0B2.4B2.7B3.2B2.0B
Intangible Assets28.7M121.7M148.6M143.2M136.9M93.4M
Common Stock Shares Outstanding402.3M402.2M405.1M417.1M414.0M446.7M
Short Term Investments158.7M504.0M769.7M358.7M433.2M350.3M
Net Invested Capital1.7B2.1B2.5B3.0B3.6B2.5B
Net Working Capital1.2B1.5B1.7B2.0B2.0B1.7B
Capital Stock402.3M402.2M405.1M414.0M476.1M447.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Double Stock

Balance Sheet is a snapshot of the financial position of Double Medical Technology at a specified time, usually calculated after every quarter, six months, or one year. Double Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Double Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Double currently owns. An asset can also be divided into two categories, current and non-current.